{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T23:42:44Z","timestamp":1769816564190,"version":"3.49.0"},"reference-count":25,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,7,16]],"date-time":"2009-07-16T00:00:00Z","timestamp":1247702400000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respirology"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background and objective:\u2003<\/jats:bold> Endogenous hydrogen sulfide (H<jats:sub>2<\/jats:sub>S) may be involved in the pathogenesis of systemic inflammation. It was investigated whether serum H<jats:sub>2<\/jats:sub>S levels differed among patients with community\u2010acquired pneumonia, those with exacerbations of COPD or control subjects, and whether H<jats:sub>2<\/jats:sub>S may be used as a surrogate marker of the need for antibiotic treatment.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> Serum H<jats:sub>2<\/jats:sub>S levels were measured in 129 patients with pneumonia or COPD exacerbations and in 72 healthy control subjects.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> The mean serum H<jats:sub>2<\/jats:sub>S concentration was 36% lower in patients with pneumonia (22.7\u2003\u00b1\u200314.6\u2003\u00b5mol\/L) than in control subjects (35.4\u2003\u00b1\u20035.3\u2003\u00b5mol\/L) (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). Serum H<jats:sub>2<\/jats:sub>S concentration did not differ between patients with acute exacerbations of COPD (33.8\u2003\u00b1\u200318.6\u2003\u00b5mol\/L) and control subjects. Within the COPD group, patients with Anthonisen type 1 exacerbations had a lower serum H<jats:sub>2<\/jats:sub>S concentration (22.5\u2003\u00b1\u200311.6\u2003\u00b5mol\/L) than control subjects, and those with type 3 exacerbations had a higher serum H<jats:sub>2<\/jats:sub>S concentration (54.2\u2003\u00b1\u200321.3\u2003\u00b5mol\/L) than control subjects. There was no difference between patients with type 2 exacerbations (41.7\u2003\u00b1\u20038.4\u2003\u00b5mol\/L) and control subjects. In patients requiring antibiotics, serum H<jats:sub>2<\/jats:sub>S concentration was 41% lower than in those not requiring antibiotics. The area under the receiver operating characteristic curve for H<jats:sub>2<\/jats:sub>S as a surrogate marker of the need for antibiotics was 0.862 (95% confidence interval: 0.805\u20130.919, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). Serum H<jats:sub>2<\/jats:sub>S levels were inversely correlated with serum CRP levels (<jats:italic>r<\/jats:italic>\u2003=\u2003\u22120.337, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01).<\/jats:p><jats:p><jats:bold>Conclusions:\u2003<\/jats:bold> Serum H<jats:sub>2<\/jats:sub>S levels may be used as a marker in lower respiratory tract infections. Further studies are required to validate the role of serum H<jats:sub>2<\/jats:sub>S levels in guiding antibiotic selection.<\/jats:p>","DOI":"10.1111\/j.1440-1843.2009.01550.x","type":"journal-article","created":{"date-parts":[[2009,7,16]],"date-time":"2009-07-16T07:46:19Z","timestamp":1247730379000},"page":"746-752","source":"Crossref","is-referenced-by-count":40,"title":["Serum hydrogen sulfide as a novel marker predicting bacterial involvement in patients with community\u2010acquired lower respiratory tract infections"],"prefix":"10.1111","volume":"14","author":[{"given":"Ya\u2010Hong","family":"CHEN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan\u2010Zhen","family":"YAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing\u2010Zhen","family":"GAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"GENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei\u2010Pei","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao\u2010Shu","family":"TANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,7,16]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00055705"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.7.at1010"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1513\/pats.2306029"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200703-456SO"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-2-196"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15591-8"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00005606"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/421997"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0211hyp"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706367"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-6270fje"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2005.10.007"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701233360402"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.21.6008"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.11.110"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02617.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.04.094"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-3023fje"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00489.2005"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.5.3205"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.02.176"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000183393.83272.de"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700391"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.04283.x"},{"key":"e_1_2_7_26_2","first-page":"3","article-title":"A multicenter study on the pathogenic agents in 665 adult patients with community\u2010acquired pneumonia in cities of China","volume":"29","author":"Liu YN","year":"2006","journal-title":"Chin. J. Tuberc. Respir. Dis"}],"container-title":["Respirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1843.2009.01550.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1843.2009.01550.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T08:03:32Z","timestamp":1697270612000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1843.2009.01550.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1440-1843.2009.01550.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1843.2009.01550.x","archive":["Portico"],"relation":{},"ISSN":["1323-7799","1440-1843"],"issn-type":[{"value":"1323-7799","type":"print"},{"value":"1440-1843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}